Patients
We conducted a retrospective cohort study of 270 patients who underwent
laparoscopic myomectomy (114 patients were treated with LESS-M and 156
patients were treated with CLM) from 1 July 2019 to 10 October 2020 at
the Second Affiliated Hospital of Wenzhou Medical University. All
surgeries were performed by senior gynecological treatment teams, among
which senior gynecologists have more than ten years of clinical
experience in myomectomy. The inclusion criteria were treatment by
LESS-M or CLM, a postoperative pathological diagnosis of hysteromyoma,
and general anesthesia during the operation. The exclusion criteria were
hematological diseases, such as coagulation disorders; Undiagnosed cause
of irregular bleeding; metabolic, hepatic, or renal complication;
pregnancy or lactation; treatment with anti-platelet aggregants; and
complicated with endometrial or cervical lesions.